Article
The synergistic effect of IDH mutation and NDRG-2 dysregulation in the progression of WHO-grade 4 astrocytomas.
Pathology, research and practice - 1 Aug 2023
Kurdi Maher, Fadul Motaz M, Alkhayyat Shadi, Sabbagh Abdulrahman J, Alsinani Taghreed, Alkhotani Alaa, Mulla Nasser, Mehboob Riffat, Fathaddin Amany A, Bamaga Ahmed, Faizo Eyad, Baeesa Saleh
Abstract excerpt
BACKGROUND: NDRG2 is a tumour suppressor gene involved in tumor growth inhibition. Its effect on tumour recurrence remains controversial. The aim of this study is to explore the dual effect of IDH mutation and NDRG2 dysregulation in WHO-Grade 4 astrocytoma recurrence. METHODS: A group of 36 patients with WHO-Grade 4 astrocytoma were examined for NDRG2 expression using protein and gene expression assays. The...
Topics
Join the communities discussing this publication.
